Related references
Note: Only part of the references are listed.Drug development for Alzheimer's disease: review
Kejing Lao et al.
JOURNAL OF DRUG TARGETING (2019)
The amyloid cascade and Alzheimer's disease therapeutics: theory versus observation
Rudy J. Castellani et al.
LABORATORY INVESTIGATION (2019)
Mechanism of amyloid protein aggregation and the role of inhibitors
Sara Linse
PURE AND APPLIED CHEMISTRY (2019)
Cyclized NDGA modifies dynamic α-synuclein monomers preventing aggregation and toxicity
Malcolm J. Daniels et al.
SCIENTIFIC REPORTS (2019)
An engineered monomer binding-protein for α-synuclein efficiently inhibits the proliferation of amyloid fibrils
Emil Dandanell Agerschou et al.
ELIFE (2019)
Additional Thioflavin-T Binding Mode in Insulin Fibril Inner Core Region
Mantas Ziaunys et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2019)
Zinc boosts EGCG's hIAPP amyloid Inhibition both in solution and membrane
Young-Ho Lee et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2019)
Suppression, disaggregation, and modulation of γ-Synuclein fibrillation pathway by green tea polyphenol EGCG
Sneha Roy et al.
PROTEIN SCIENCE (2019)
Microfluidic Diffusion Platform for Characterizing the Sizes of Lipid Vesicles and the Thermodynamics of Protein-Lipid Interactions
Hongze Gang et al.
ANALYTICAL CHEMISTRY (2018)
Amyloid Polymorphism in the Protein Folding and Aggregation Energy Landscape
Jozef Adamcik et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Epigallocatechin-3-gallate remodels apolipoprotein A-I amyloid fibrils into soluble oligomers in the presence of heparin
David Townsend et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Probing the inhibitory potency of epigallocatechin gallate against human γB-crystallin aggregation: Spectroscopic, microscopic and simulation studies
Susmitnarayan Chaudhury et al.
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY (2018)
Self-inhibition of insulin amyloid-like aggregation
Mantas Ziaunys et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2018)
Stability of tea polyphenols solution with different pH at different temperatures
Liang Zeng et al.
INTERNATIONAL JOURNAL OF FOOD PROPERTIES (2017)
Aggregation of Full-length Immunoglobulin Light Chains from Systemic Light Chain Amyloidosis (AL) Patients Is Remodeled by Epigallocatechin-3-gallate
Kathrin Andrich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Why do trials for Alzheimer's disease drugs keep failing? A discontinued drug perspective for 2010-2015
Dev Mehta et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
Probing the inhibitory activity of epigallocatechin-gallate on toxic aggregates of mutant (L84F) SOD1 protein through geometry based sampling and steered molecular dynamics
E. Srinivasan et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2017)
Creutzfeldt-Jacob disease: new directions in diagnosis and therapeutics
Aseel Al-Ansari et al.
JOURNAL OF NEUROLOGY (2017)
Rationally Designed Peptides and Peptidomimetics as Inhibitors of Amyloid-β (Aβ) Aggregation: Potential Therapeutics of Alzheimer's Disease
Deepti Goyal et al.
ACS COMBINATORIAL SCIENCE (2017)
(-)-Epigallocatechin-3-gallate (EGCG) inhibits fibrillation, disaggregates amyloid fibrils of alpha-synuclein, and protects PC12 cells against alpha-synuclein-induced toxicity
Juan Zhao et al.
RSC ADVANCES (2017)
Oxidized epigallocatechin gallate inhibited lysozyme fibrillation more strongly than the native form
Ting-Ting An et al.
REDOX BIOLOGY (2017)
Critical Influence of Cosolutes and Surfaces on the Assembly of Serpin-Derived Amyloid Fibrils
Michael W. Risor et al.
BIOPHYSICAL JOURNAL (2017)
Inhibitory Mechanism of Epigallocatechin Gallate on Fibrillation and Aggregation of Amidated Human Islet Amyloid Polypeptide
Zhi-Xue Xu et al.
CHEMPHYSCHEM (2017)
Microfluidic Diffusion Analysis of the Sizes and Interactions of Proteins under Native Solution Conditions
Paolo Arosio et al.
ACS NANO (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Certain (-)-epigallocatechin-3-gallate (EGCG) auto-oxidation products (EAOPs) retain the cytotoxic activities of EGCG
Yaqing Wei et al.
FOOD CHEMISTRY (2016)
Polyphenols in dementia: From molecular basis to clinical trials
Silvia Molino et al.
LIFE SCIENCES (2016)
Epigallocatechin Gallate (EGCG) Inhibits Alpha-Synuclein Aggregation: A Potential Agent for Parkinson's Disease
Yan Xu et al.
NEUROCHEMICAL RESEARCH (2016)
Challenges in detecting disease modification in Parkinson's disease clinical trials
Dilan Athauda et al.
PARKINSONISM & RELATED DISORDERS (2016)
Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation
Paolo Arosio et al.
NATURE COMMUNICATIONS (2016)
A Fragment-Based Method of Creating Small-Molecule Libraries to Target the Aggregation of Intrinsically Disordered Proteins
Priyanka Joshi et al.
ACS COMBINATORIAL SCIENCE (2016)
Stoichiometry and Affinity of Thioflavin T Binding to Sup35p Amyloid Fibrils
Anna I. Sulatskaya et al.
PLOS ONE (2016)
Inhibition of protein aggregation and amyloid formation by small molecules
Andrew J. Doig et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2015)
Latent analysis of unmodified biomolecules and their complexes in solution with attomole detection sensitivity
Emma V. Yates et al.
NATURE CHEMISTRY (2015)
Immunotherapeutic Approaches for Alzheimer's Disease
Thomas Wisniewski et al.
NEURON (2015)
pH-Driven Polymorphism of Insulin Amyloid-Like Fibrils
Tomas Sneideris et al.
PLOS ONE (2015)
Structural characteristics of (-)-epigallocatechin-3-gallate inhibiting amyloid Aβ42 aggregation and remodeling amyloid fibers
Yun Liu et al.
RSC ADVANCES (2015)
Rising to the Challenges of Clinical Trial Improvement in Parkinson's Disease
Soania Mathur et al.
JOURNAL OF PARKINSONS DISEASE (2015)
Polymorphism of amyloid-like fibrils can be defined by the concentration of seeds
Tomas Sneideris et al.
PEERJ (2015)
Looking for a generic inhibitor of amyloid-like fibril formation among flavone derivatives
Tomas Sneideris et al.
PeerJ (2015)
The green tea polyphenol (-)-epigallocatechin gallate prevents the aggregation of tau protein into toxic oligomers at substoichiometric ratios
Heike J. Wobst et al.
FEBS LETTERS (2015)
Flavone Derivatives as Inhibitors of Insulin Amyloid-Like Fibril Formation
Ricardas Malisauskas et al.
PLOS ONE (2015)
Gallic acid, one of the components in many plant tissues, is a potential inhibitor for insulin amyloid fibril formation
Jayaraman Jayamani et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Master and Slave Relationship Between Two Types of Self-Propagating Insulin Amyloid Fibrils
Weronika Surmacz-Chwedoruk et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2014)
Surface Effects on Aggregation Kinetics of Amyloidogenic Peptides
Robert Vacha et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
The Presence of an Air-Water Interface Affects Formation and Elongation of α-Synuclein Fibrils
Silvia Campioni et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases
Jing L. Guo et al.
NATURE MEDICINE (2014)
The amyloid state and its association with protein misfolding diseases
Tuomas P. J. Knowles et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Solution conditions determine the relative importance of nucleation and growth processes in α-synuclein aggregation
Alexander K. Buell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Chemical kinetics for drug discovery to combat protein aggregation diseases
Paolo Arosio et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Lysosomes and α-synuclein form a dangerous duet leading to neuronal cell death
Mathieu Bourdenx et al.
FRONTIERS IN NEUROANATOMY (2014)
Alzheimer's disease drug-development pipeline: few candidates, frequent failures
Jeffrey L. Cummings et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Oxidized quercetin inhibits α-synuclein fibrillization
Min Zhu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Inhibiting toxic aggregation of amyloidogenic proteins: A therapeutic strategy for protein misfolding diseases
Biao Cheng et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Protein Folding and Aggregation into Amyloid: The Interference by Natural Phenolic Compounds
Massimo Stefani et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Toward the Molecular Mechanism(s) by Which EGCG Treatment Remodels Mature Amyloid Fibrils
Fernando L. Palhano et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Atomic structure and hierarchical assembly of a cross-β amyloid fibril
Anthony W. P. Fitzpatrick et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Surface adsorption considerations when working with amyloid fibrils in multiwell plates and Eppendorf tubes
Amber N. Murray et al.
PROTEIN SCIENCE (2013)
MODULATORS OF AMYLOID PROTEIN AGGREGATION AND TOXICITY: EGCG AND CLR01
Aida Attar et al.
TRANSLATIONAL NEUROSCIENCE (2013)
The role of two natural flavonoids on human amylin aggregation
Mohammad-Hossein Aarabi et al.
AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY (2012)
Alzheimer's disease: clinical trials and drug development (vol 9, pg 702, 2010)
F. Mangialasche et al.
LANCET NEUROLOGY (2011)
Molecular mechanism of Thioflavin-T binding to amyloid fibrils
Matthew Biancalana et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
Interactions between Amyloidophilic Dyes and Their Relevance to Studies of Amyloid Inhibitors
Alexander K. Buell et al.
BIOPHYSICAL JOURNAL (2010)
Lysosomal Degradation of α-Synuclein in Vivo
Sally K. Mak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
Jan Bieschke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Alzheimer's disease: clinical trials and drug development
Francesca Mangialasche et al.
LANCET NEUROLOGY (2010)
Primary Steps of pH-Dependent Insulin Aggregation Kinetics are Governed by Conformational Flexibility
Juergen Haas et al.
CHEMBIOCHEM (2009)
A synergistic small-molecule combination directly eradicates diverse prion strain structures
Blake E. Roberts et al.
NATURE CHEMICAL BIOLOGY (2009)
The anti-amyloidogenic effect is exerted against Alzheimer's β-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure
Mie Hirohata et al.
BIOCHEMISTRY (2007)
Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models
Dagmar E. Ehrnhoefer et al.
HUMAN MOLECULAR GENETICS (2006)
Inhibition of amyloid fibril formation by polyphenols: Structural similarity and aromatic interactions as a common inhibition mechanism
Y Porat et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2006)
Stability of tea polyphenol (-)-epigallocatechin-3-gallate and formation of dimers and epimers under common experimental conditions
SM Sang et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2005)
Ethanol-perturbed amyloidogenic self-assembly of insulin: Looking for origins of amyloid strains
W Dzwolak et al.
BIOCHEMISTRY (2005)
The structural variation in the incubation products of (-)-epigallocatechin gallate in neutral solution suggests its breakdown pathways
T Hatano et al.
HETEROCYCLES (2005)
Template-controlled conformational patterns of insulin fibrillar self-assembly reflect history of solvation of the amyloid nuclei
W Dzwolak et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2005)
Insulin forms amyloid in a strain-dependent manner: An FT-IR spectroscopic study
W Dzwolak et al.
PROTEIN SCIENCE (2004)
Effect of environmental factors on the kinetics of insulin fibril formation: Elucidation of the molecular mechanism
L Nielsen et al.
BIOCHEMISTRY (2001)
Share Paper
